Cullen/Frost Bankers, Inc. Boston Scientific Corp Transaction History
Cullen/Frost Bankers, Inc.
- $7.21 Billion
- Q4 2024
A detailed history of Cullen/Frost Bankers, Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Cullen/Frost Bankers, Inc. holds 364,274 shares of BSX stock, worth $34.8 Million. This represents 0.45% of its overall portfolio holdings.
Number of Shares
364,274
Previous 369,372
1.38%
Holding current value
$34.8 Million
Previous $31 Million
5.11%
% of portfolio
0.45%
Previous 0.43%
Shares
25 transactions
Others Institutions Holding BSX
# of Institutions
1,668Shares Held
1.22BCall Options Held
8.76MPut Options Held
9.42M-
Vanguard Group Inc Valley Forge, PA133MShares$12.7 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY126MShares$12.1 Billion0.22% of portfolio
-
State Street Corp Boston, MA64MShares$6.11 Billion0.23% of portfolio
-
Primecap Management CO Pasadena, CA36.9MShares$3.53 Billion2.61% of portfolio
-
Wellington Management Group LLP Boston, MA36.2MShares$3.45 Billion0.61% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $137B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...